These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 580196)

  • 21. [The pharmacological properties of karazedin].
    Barkov NK; Serpilina NM; Surkova LA; Sharkova LM; Rusakov DIu; Tiurina IV
    Eksp Klin Farmakol; 1994; 57(2):4-6. PubMed ID: 7911367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
    Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
    Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of various tryptolines (tetrahydro-beta-carbolines) on 5-hydroxytryptamine receptors.
    Holman RB
    Prog Clin Biol Res; 1982; 90():167-81. PubMed ID: 6287489
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental and clinical characteristics of the Soviet antidepressant inkasan].
    Mashkovskiĭ MD; Andreeva NI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):410-3. PubMed ID: 6720183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A; Serrano JS; Jané F; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J; Rogóz Z; Sowińska H; Zalewski Z
    Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacological study of propane-1,2-diol.
    Singh PP; Junnarkar AY; Seshagirirao C; Kaushal R; Naidu MU; Varma RK; Tripathi RM; Shridhar DR
    Arzneimittelforschung; 1982; 32(11):1443-6. PubMed ID: 6891251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological study of the new Soviet antidepressant, inkazan].
    Andreeva NI; Mashkovskii MD
    Farmakol Toksikol; 1980; 43(2):133-7. PubMed ID: 7002587
    [No Abstract]   [Full Text] [Related]  

  • 30. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies of CNS agents. Part 1: The Free-Wilson analysis of acute toxicity and sedative effect of some 1,2,3,4-tetrahydro-beta-carbolines.
    Mokrosz JL; Dukat M; Misztal S; Chojnacka-Wójcik E; Tatarczyńska E
    Pharmazie; 1990 Oct; 45(10):765-7. PubMed ID: 2089388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity of 3,3',4,4'-tetrachloroazoxybenzene in rats and mice.
    van Birgelen AP; Hébert CD; Wenk ML; Grimes LK; Chapin RE; Travlos GS; Mahler J; Bucher JR
    Toxicol Appl Pharmacol; 1999 May; 156(3):206-21. PubMed ID: 10222313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of beta-carboline derivatives on the evoked activity of hippocampal neurons].
    Glushankov PG; Pliashkevich IuG; Skrebitskiĭ VG; Demushkin VP
    Biull Eksp Biol Med; 1984 Aug; 98(8):211-3. PubMed ID: 6147169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
    Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-beta-carboline ring system. Synthesis and preliminary in vivo studies.
    Cegła MT; Boksa J; Chojnacka-Wójcik E; Misztal S
    Pharmazie; 1996 Dec; 51(12):932-6. PubMed ID: 8985983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An experimental study of the psychotropic action of pyrazidol].
    Mashkovskiĭ MD; Andreeva NI
    Farmakol Toksikol; 1975; 38(1):5-10. PubMed ID: 1078660
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological properties of tetrahydronorharmane (tryptoline).
    Rommelspacher H; Kauffmann H; Cohnitz CH; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):83-91. PubMed ID: 560635
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioural and electrocortical power spectrum effects of 5-methoxytryptoline and other analogs after intraventricular administration in rats.
    Nistico G; De Sarro GB; Langer SZ
    Eur J Pharmacol; 1987 Oct; 142(1):121-8. PubMed ID: 3691630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.